Abcellera Biologics Inc (ABCL) valuation · rev $75.1M
Abcellera Biologics Inc (ABCL) rev $75.1M.
| Metric | Value |
|---|---|
| Market cap | $1.12B |
| Revenue | $75.1M |
| P/S | 14.9 |
ABCL valuation FAQ
What is ABCL's market cap?
Abcellera Biologics Inc (ABCL) market cap is $1.12B on the latest cached fundamentals snapshot.
What is ABCL's latest revenue?
Latest cached Abcellera Biologics Inc (ABCL) revenue was $75.1M. Statements: https://lician.com/financials/abcl
What is ABCL's price-to-sales ratio?
Abcellera Biologics Inc (ABCL) price-to-sales (P/S) is 14.9, cached market cap $1.12B divided by revenue $75.1M.
How many ABCL valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Abcellera Biologics Inc (ABCL): Market cap, Revenue, and P/S.
Where is ABCL valuation listed?
Cached valuation multiples for Abcellera Biologics Inc (ABCL) are listed at https://lician.com/valuation/abcl.
Not investment advice. Cached rows, not a live tape.